Home Blog

The Crypto Dip is a Fresh Shot at Exposure to the Top Market Theme (HUT, ISWH, HIVE, SBNY, RIOT, SI, BKKT, BITF, MSTR)

By
Rachel Kim
-
0

Crypto is dead. Long live crypto.

This market, perhaps above all others, is the ultimate roller coaster. Crypto investors invented the term “HODL” – or Hold On for Dear Life – for a reason. It isn’t easy to stick with a bet that regularly suffers from bipolar disorder.

As Sinatra crooned, “That’s life (That’s life), That’s what all the people say. You’re riding high in April, shot down in May. But I know I’m gonna change that tune… When I’m back on top, back on top in June.”

Such is life in the crypto space. However, volatility notwithstanding, the net result is that Bitcoin is the best performing major asset in the world over the past 2 years, up over 400% in that time. 

HODL, indeed.

For those who missed that move, there are plenty of interesting ways to make up ground. For example, many publicly traded stocks tethered to the crypto markets often outperform Bitcoin during periods of strength. 

As we move toward a world dominated by mainstream acceptance of digital currencies, digital goods, tokenization, and alternative forms of finance, investors with no exposure to stocks in the space may find their portfolios left behind.

That puts the current Bitcoin dip in a productive light. With that in mind, we take a look below at some of the most interesting stocks tied to the crypto theme that could form the foundation for an interesting shopping list over coming weeks.

Hut 8 Mining Corp. (Nasdaq:HUT) bills itself as a cryptocurrency mining and blockchain infrastructure company focused solely on mining bitcoin. 

The stock provides investors with direct access to bitcoin, without the technical complexity or constraints of purchasing the underlying cryptocurrency. In other words, HUT is about as a straightforward as it gets in terms of being a proxy for crypto exposure.

Hut 8 Mining Corp. (Nasdaq:HUT) recently announced the appointment of Josh Rayner to the new role of Vice President, Sales, effective February 21, 2022. Mr. Rayner joins Hut 8 to lead sales with a focus on the Company’s recently acquired data center and managed services business under the direction of CEO Jaime Leverton.

“We are excited to welcome Josh to our team to help us strengthen our existing position and expand our new customer base,” said Jaime Leverton, Chief Executive Officer of Hut 8. “As both a leader with diverse experience in the data center realm and a passionate champion of digital assets, Josh is well positioned to support our continued momentum and will be an asset to our team.”

Even in light of this news, HUT has had a rough past week of trading action, with shares sinking something like -17% in that time. That said, chart support is nearby, and we may be in the process of constructing a nice setup for some movement back the other way. 

Hut 8 Mining Corp. (Nasdaq:HUT) managed to rope in revenues totaling $50.3M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 774.8%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels exceeding current liabilities ($375.5M against $21.9M).

ISW Holdings (OTC US:ISWH) could be the most interesting name on this list mainly because it has very real and growing operations with top-tier partnerships, but it likely still trades at a steep discount to other crypto players because it’s still on the OTC market. Given the scale of the company’s operations, it may not be long before it moves up to a listing on a major exchange, which could unlock a lot of value for its shareholders.

The stock is also outperforming its peers over the past three months – a period when most of the stocks in the crypto space have been crushed as BTC pulls back. During that period, ISWH is actually one of only a very select number in the space to avoid big losses. That relative strength may be an important sign of things to come.

ISW Holdings (OTC US:ISWH) has also been advancing its own interests over that period, readying for the launch of its ambitious project in the Southeastern US, where it has laid out a 10-phase process to switch on at least 200 megawatts of mining capacity in its hosting partnership with global superpower Bitmain Technologies.

In a big release out yesterday, ISWH announced the full live launch of that project, stating that it has now officially powered up the first 8 POD5 units at the site (each POD5 unit contains 280 mining rigs now actively mining Bitcoin).

“This is a tremendous day for ISW Holdings and our shareholders,” stated Alonzo Pierce, President and Chair of ISW Holdings. “After months of hard work, and after overcoming a series of obstacles related to the unpredictable global macroeconomic context, we are very proud to announce that the Company is now officially hosting client mining services and mining Bitcoin at scale in our 200MW mining and hosting project.”

According to the company’s release, once fully completed, at current energy price spreads and agreements, this first 20MW Phase is expected to generate nearly $9 million in annualized revenues for the Company. Management expects to begin building out phases 2 thru 10 starting in April, targeting 200MW of power across 200 POD5 units, each driving 280 state-of-the-art mining rigs, by January 2023.

ISW Holdings (OTC US:ISWH) President Pierce added, “We are now in the process of deploying the first 20MW Phase 1 buildout. We will continue to energize the entire Phase 1 project over the next couple of weeks and then swiftly move on to Phase 2.” As if that wasn’t enough to drive interest, according to a recent update from the company, following the full deployment and activation of all 200 MW of power, ISW will reportedly have the opportunity to increase its facility to 500 MW of power, conceivably positioning the company as one of the largest crypto mining operations.

Hive Blockchain Technologies Ltd. (Nasdaq:HIVE) went public in 2017 as the first cryptocurrency mining company with a green energy and ESG strategy.

The company defines itself as a growth-oriented technology stock in the emergent blockchain industry. HIVE owns state-of-the-art, green energy-powered data centre facilities in Canada, Sweden, and Iceland, where it claims to source only green energy to mine on the cloud and HODL both Ethereum and Bitcoin. Since the beginning of 2021, HIVE has held in secure storage the majority of its ETH and BTC coin mining rewards. 

Hive Blockchain Technologies Ltd. (Nasdaq:HIVE) recently announced record earnings for the third quarter ended December 31, 2021, including news that revenue rose to $68.2 million, up 30% compared with last quarter, and 397% since the same quarter last year. Net income reached $64.2 million, up 7% from last quarter, and 273% since the prior year. Hive reported combined liquid BTC and ETH with a gross value of $168 million, up 11x from $15 million a year ago. HIVE ended the current December quarter holding 1,813 Bitcoin (“BTC”) worth $83.1 million and 23,290 Ether (“ETH”) worth $84.9 million.

Frank Holmes, HIVE’s Executive Chairman, stated “We wish to again thank our loyal shareholders for believing in our vision to mine both Ethereum and Bitcoin to generate robust cash flow returns on invested capital and we believe our results continue to validate the significant contribution to our strategy to mine both BTC and ETH and HODL as many coins as possible.”

Recent action has seen 8% tacked on to share pricing for the name in the past month, but that move comes in the context of a larger bearish trend. Market participants may want to pay attention to this stock. HIVE has a past featuring a litany of sudden rips to the upside. What’s more, the listing has seen a growing influx of trading interest, with the stock’s recent average trading volume running 63% above the average volume levels in play in this stock over the longer term. 

Hive Blockchain Technologies Ltd. (Nasdaq:HIVE) currently carries a capital value in the market of $819 million and sports a significant war chest ($180.4M) of cash on the books, which must be weighed relative to about $12.9M in total current liabilities. HIVE is pulling in trailing 12-month revenues of $172.2M. However, the company is seeing declines on the top-line on a quarterly y/y basis, with revenues falling at -22.9%.

Other top stocks in the cryptocurrency space include Signature Bank (Nasdaq:SBNY), Riot Blockchain Inc. (Nasdaq:RIOT), Silvergate Capital Corp. (NYSE:SI), Bakkt Holdings Inc. (NYSE:BKKT), Bitfarms Ltd. (Nasdaq:BITF), and MicroStrategy Inc. (Nasdaq:MSTR).

S&P 500 (VIX) calls for another bearish day

By
Rachel Kim
-
0

Markets bounced back after a horrible selloff yesterday on the back of the Fed announcement. It’s kind of a weird spot as there isn’t a lot of trading to do intraday. Things opened higher and are trading in a relatively tight range.

I’m watching to see if the VIX starts to crack anytime soon. We do have a bearish crossover on the hourly chart. But that low it made the other day after the Fed announcement gives me pause.

VIX Hourly Chart

The high from the other day in the SPY was $313.84. I’ll use that as my resistance area for the time being. More than likely, we’ll trade in a range from around $295-$310 for quite a while as we try to figure out the impact of both the elections and this pandemic.

Also, keep an eye on the VVIX. The low from the other day was $108.59. If we start closing hourly and then daily below that level, we should get a brief rally as it heads towards $105.

Wall Street looking to bounce back with green futures: SPY calls

By
Rachel Kim
-
0
WallStreet_bounce

Futures are up this morning. The SPY is currently sitting at 324.01 in the premarket.

In pre-market since Friday it has risen but not getting higher than 324.50. In the premarket charts at the moment we see that the 10 moving average line is slightly above the 20 moving average line on 5,10 and 15 minute charts.

Additionally, volume is about the same as Friday. The SPY seems to be headed for a gap up here of almost a point. Given the TRIN end of day Friday, the futures currently and the moving averages at the moment, Wall Street may be eyeing for a move up today if the SPY doesn’t open too high.

If it jumps right away, the we know for sure that the gap will be filled today. But if it drops, I would wait for a reversal off support line or if it just moves sides ways I’ll look for buying volume to confirm my decision. 

Volume, like Friday, will be a big indicator today of where we are going. In order for this trading plan to be in play SPY must remain trading above that key support level near 322.50. If I see this it would trigger a buy to open followed by sell to close CALL option move today.

Finally, know that because of recent volatility, these options will be more expensive than usual. Resistance:  324.11, 324.23, 324.50 Support: 323.63, 323.33, 323 Today’s Trade of The Day is SPY February 7 325 CALLS

Bitcoin Snaps Back to $69K in Short Squeeze — Analysts Warn Rally May Not Last

By
Daniel Cruz
-
0

Bitcoin surged back near $69,000 on Wednesday, rallying more than 10% from Tuesday’s low as crypto markets staged a broad relief rally after weeks of persistent selling pressure. The sharp move higher caught many traders leaning the wrong way, triggering a cascade of short liquidations across the market.

Ethereum (ETH), Dogecoin (DOGE), Solana (SOL), and Cardano (ADA) all posted double-digit gains, extending a move that offered a welcome reprieve after a prolonged stretch of pessimism and fears of a next leg lower.

Digital asset stocks joined the rally as well. Stablecoin issuer Circle (CRCL) surged 34% following its earnings report, while crypto exchange Coinbase (COIN) jumped 14%. Strategy (MSTR), the largest corporate holder of bitcoin, climbed 9%, and ether treasury firm BitMine advanced 12%.

Analysts: Treat the Bounce With Caution

Despite the sharp move higher, analysts were quick to pump the brakes on calling this the start of a new bull run.

Joel Kruger, market strategist at LMAX Group, pointed to extreme fear and bearish positioning as the primary driver of the Wednesday move rather than any fundamental shift in the market.

“Crypto assets have been heavily pressured in recent months and overdue for a technical bounce,” Kruger wrote. “The market had built up a meaningful tactical short bias, leaving it vulnerable to sharp squeezes on limited headlines.”

He added a note of caution about the rally’s durability. “Given the abrupt nature of the rally and the absence of a clear trigger — particularly against the backdrop of thinner liquidity conditions — the advance should be treated with caution,” Kruger said.

Funds Chasing Altcoins and Options

Joshua Lim, global co-head of markets at FalconX, said his desk is seeing heavy demand for bullish bets on Ethereum in the options market. Traders are specifically buying call options and call spreads in the $2,000–$2,200 range over the next two to three weeks, seeking to profit from further near-term upside.

Lim noted that some funds are also chasing the rally by rotating into higher-volatility altcoins and using options to amplify potential gains — a sign that risk appetite has picked up sharply following the rebound.

$7.49 Billion in Options Expiring Friday

Adding complexity to the near-term picture, roughly 115,000 BTC options worth approximately $7.49 billion are set to expire Friday at month-end. The so-called “max pain” level — the price at which the largest number of options expire worthless — currently sits around $75,000, according to Wintermute OTC trader Jasper De Maere.

The max pain point can sometimes act as a magnetic level heading into expiry, though De Maere noted that dealer positioning appears weak. “Fundamental indicators still remain unconvincing that this strength will see much follow through,” he added.

Key Resistance Levels to Watch

Technically, bitcoin faces stiff resistance in the $70,000 to $72,000 zone, where recent rallies have stalled as sellers stepped in. Breaking those levels on a sustained basis would be the first challenge in turning the current bounce into a durable move higher.

Bitfinex analysts pointed to $78,000 as an even more critical level, where the “True Market Mean” — an on-chain valuation metric that estimates bitcoin’s fair value based on actual capital flows into the network — currently sits. That level must be reclaimed on a sustained weekly basis before the structural picture meaningfully improves, according to Bitfinex.

Bottom Line

Wednesday’s rally was sharp, broad-based, and provided welcome relief after weeks of relentless selling. But the absence of a clear fundamental catalyst, combined with looming resistance levels and a massive options expiry on Friday, means crypto traders should approach the rebound with disciplined caution. The difference between a short squeeze and the start of a new trend will be determined by whether bitcoin can break and hold above $72,000 — and eventually reclaim $78,000 — in the days and weeks ahead.

Tags: Bitcoin, BTC, Ethereum, ETH, Solana, SOL, Dogecoin, DOGE, Cardano, ADA, Coinbase, COIN, Circle, CRCL, Strategy, MSTR, BitMine, crypto rally, short squeeze, bitcoin resistance, crypto news, altcoins

Oragenics Positions ONP-002 as Potential First-Ever Pharmacological Treatment for Concussion in Landmark 2026 Push

By
Daniel Cruz
-
0
Hot Stocks

Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has laid out an ambitious series of milestones for 2026 — all centered on a drug candidate targeting one of the largest unmet medical needs in neurology: concussion and mild traumatic brain injury (mTBI).

The company’s lead candidate, ONP-002, is a novel intranasal neurosteroid designed to be the first pharmacological treatment ever approved for concussion. That claim is not marketing hyperbole — it is a factual gap in medicine. Despite millions of Americans experiencing traumatic brain injuries every year, not a single FDA-approved drug exists specifically for concussion or mTBI.

A Medical White Space Hiding in Plain Sight

Traumatic brain injuries affect more Americans each year than stroke, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and ALS — combined. That statistic, based on aggregated U.S. incidence estimates, underscores the scale of the problem. And yet, according to the Centers for Disease Control and Prevention (CDC), concussion and mTBI remain the most prominent neurological condition without an FDA-approved therapeutic.

Sports injuries and recreational accidents drive a large portion of the 1.7 to 3.8 million TBI cases reported annually in the U.S. For athletes, military personnel, and accident survivors, treatment today amounts to rest and symptom management — nothing pharmacological, nothing neuroprotective, nothing that directly addresses the underlying cascade of inflammation and oxidative stress that defines a concussion at the cellular level.

The global concussion market is projected to reach over $9 billion by 2030, and ONP-002, if approved, would also enter the nasal drug delivery market expected to reach nearly $93 billion by 2030.

“We remain deeply committed to delivering a much-needed therapeutic solution for patients suffering from concussion and mTBI. Based on positive pre-clinical and Phase 1 clinical safety and efficacy data with no competition in the clinic to date, ONP-002, if approved, shows potential to become the first commercial treatment for a projected $9 billion global concussion market.” — Janet Huffman, CEO, Oragenics, Inc.

Why Intranasal Delivery Is the Right Tool for Brain Injury

Concussions are a time-sensitive emergency. The inflammatory cascade that damages neurons following a traumatic brain event begins almost immediately, which means any effective therapeutic must reach the brain quickly. ONP-002’s intranasal delivery system is engineered precisely for this purpose — bypassing the blood-brain barrier to deliver medication directly and efficiently to the central nervous system.

This approach positions ONP-002 at the intersection of two massive and growing markets. If approved, it would not only be a first-in-class concussion drug but a commercially positioned asset within one of pharma’s fastest-growing delivery modalities.

2026 Milestones: What to Watch

Oragenics has outlined a clear set of value-driving catalysts for the year ahead, anchored by its Phase 2a clinical trial in Australia:

Near-term Phase 2a site onboarding and first patient dosing — All regulatory and ethics approvals have been submitted. Site activation is pending resolution of a hospital consolidation in Victoria, Australia, where five hospitals are merging to form Bayside Health.

Interim Phase 2a data throughout 2026 — The 40-patient, randomized, placebo-controlled trial will generate rolling data readouts, with final results expected in Q4 2026.

FDA IND submission for U.S. trials — Oragenics is advancing toward an Investigational New Drug application to bring ONP-002 into the U.S. clinical pipeline.

Ongoing strategic partnership development — The company is pursuing collaborations that could accelerate or expand the clinical program.

Trial Design: 40 Patients, 30 Days, Emergency-Room Enrollment

The Phase 2a trial is a randomized, placebo-controlled study enrolling 40 patients who meet eligibility criteria based on CT scans, presenting symptoms, and emergency room or hospital admission. The dosing protocol calls for first administration within 12 hours of the concussive event — a window that aligns with ONP-002’s mechanism of early neuroprotection.

Patients will then continue treatment and evaluation for up to 30 days, with follow-up visits including nasal examinations, physical checks, and neurocognitive testing. The trial’s primary endpoints cover safety and tolerability, with feasibility assessed through participant compliance. This Phase 2a design is structured to generate both the safety record and proof-of-concept efficacy signal needed to support a larger pivotal trial.

The Operational Infrastructure Is Already Built

One of the more underappreciated aspects of Oragenics’ current position is the operational groundwork it completed over the past 12 months:

  • U.S.-based manufacturing: The company moved drug production out of China, partnering with Sterling Pharma Solutions for FDA cGMP manufacturing in Cary, North Carolina.
  • CRO partnership: Southern Star Research was selected to manage the Phase 2a trial.
  • AI drug discovery: A strategic collaboration with Receptor.AI — a proprietary AI-driven platform identifying optimal receptor binding profiles — was established, with potential to expand Oragenics’ molecular portfolio beyond ONP-002.

On the financial side, the company raised $16.5 million through a public offering of Series H convertible preferred stock and warrants, carries zero debt, and has stated the Phase 2a trial is fully funded — providing a clear runway through the Q4 2026 data readout.

The Australia Delay: Context Matters

Oragenics’ Phase 2a trial has faced a modest delay tied to a large-scale health system consolidation in Victoria, Australia. Five hospitals are merging to form Bayside Health, and the resulting organizational transition has delayed final verification of the Human Research Ethics Committee (HREC) approval required for clinical site activation.

CEO Janet Huffman described the delay as external and administrative in nature. The company has received the necessary regulatory approvals, and site onboarding is sequenced around the completion of that governance process. The delay extends the original timeline by several months but does not alter the trial design, patient population, or the scientific thesis behind ONP-002.

The Bottom Line

Oragenics is advancing into a genuine white space in medicine — one that has resisted treatment for decades not because the need is small, but because developing a drug that reaches the brain fast enough to matter has been technically difficult. ONP-002’s intranasal mechanism, backed by positive pre-clinical and Phase 1 data, is the company’s answer to that challenge.

With a fully funded Phase 2a trial, a zero-debt balance sheet, domestic manufacturing infrastructure, and a Q4 2026 data readout on the horizon, Oragenics has built the operational foundation for what could be a transformative clinical and commercial catalyst. For investors tracking emerging biotech opportunities in neurology, the ONP-002 program deserves close attention in 2026.

For more information, visit oragenics.com or follow OGEN on NYSE American.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investing in clinical-stage biotechnology companies involves substantial risk. Drug candidates referenced herein have not been approved by the FDA. Clinical trial results are inherently uncertain. Always consult a licensed financial advisor before making investment decisions. This content may have been compensated. Please review all SEC filings and company disclosures before investing in OGEN or any other security.

Warren Buffett Might Be Trimming His Apple Holdings Again — And Here’s Why It Matters

By
Morgan Winters
-
0

If you’ve been following Warren Buffett’s moves lately, you might have noticed something interesting buried in Berkshire Hathaway’s latest quarterly report. It looks like the Oracle of Omaha may have quietly sold off more Apple shares during the third quarter — continuing what’s become one of the most talked-about investment decisions of 2024.

Here’s what caught investors’ attention: Berkshire’s recent filing shows that the cost basis of its consumer products equity holdings dropped by about $1.2 billion compared to the previous quarter. Now, since Apple dominates that category in Berkshire’s portfolio, it’s a pretty safe bet that this decline means Buffett and his team have been selling more of those iPhone maker shares.

And honestly, the timing makes sense. Apple’s stock absolutely soared in the third quarter, jumping more than 24%. For someone like Buffett, who’s always looking for the right moment to lock in gains, that kind of rally would’ve been hard to ignore.

A Surprising Shift for a Long-Term Believer

What’s really turned heads this year is just how much Apple stock Buffett has been offloading. Throughout 2024, he’s sold off a staggering two-thirds of Berkshire’s Apple position — a move that caught many people off guard, considering Buffett’s legendary reputation for buying and holding for the long haul. Even after trimming the position again in the second quarter of this year, Apple was still Berkshire’s biggest holding as of the end of June, with 280 million shares worth around $57 billion.

We won’t know the exact details until Berkshire files its 13F with the Securities and Exchange Commission later this month. That regulatory filing will spell out precisely what happened with individual stock holdings through September 30, so investors should get a clearer picture soon.

So Why Is Buffett Selling?

Buffett himself has previously suggested that taxes played a role in his decision to reduce the Apple stake. But let’s be real — when you’re selling that much stock, there’s probably more to the story. Many market watchers think Buffett might be concerned about Apple’s valuation getting a bit stretched. Others believe it’s simply smart portfolio management. After all, at one point, Apple made up more than half of Berkshire’s entire equity portfolio. That’s a lot of eggs in one basket, even if it’s a pretty great basket.

Here’s what’s especially notable: Berkshire has now been a net seller of stocks for 12 consecutive quarters. In the third quarter alone, the company raised over $6 billion in cash. That’s a lot of dry powder sitting on the sidelines.

And if you’re wondering whether Buffett sees trouble ahead, consider this: his once-favorite metric for gauging whether the overall stock market is overvalued — which compares the total value of all U.S. publicly traded stocks to the country’s entire gross national product — has climbed to an all-time high. Buffett himself once described this level as “playing with fire.”

Make of that what you will, but it certainly seems like the 94-year-old investing legend is being extra cautious right now. Whether he’s simply being prudent or sees storm clouds on the horizon, investors will be watching his next moves closely.

Starbucks Streamlines: 1,100 Corporate Roles Eliminated

By
Daniel Cruz
-
0

Starbucks struggles to make a comeback

Starbucks is undergoing a significant restructuring, announcing the layoff of 1,100 corporate employees and the decision to leave several hundred open positions unfilled.1 CEO Brian Niccol delivered the news to corporate staff on Monday, emphasizing the company’s need to adapt to changing market conditions.

Crucially, these cuts will not impact the baristas and staff working in Starbucks cafes.2 The focus is squarely on the company’s corporate structure.3

In his message, Niccol explained that the restructuring aims to “simplify our structure, removing layers and duplication and creating smaller, more nimble teams.” He outlined the goals as operating more efficiently, increasing accountability, reducing complexity, and driving better integration.4 Ultimately, the company aims to be “more focused and able to drive greater impact on our priorities.”5

This move comes at a pivotal time for Starbucks. The company has faced four consecutive quarters of declining same-store sales, a clear indicator of shifting consumer preferences.6 With customers increasingly opting for more budget-friendly alternatives in key markets like the U.S. and China, Starbucks is under pressure to revitalize its operations.

Since taking over as CEO last year, Niccol has been actively working to revamp the company, including initiatives aimed at speeding up service.7 This corporate restructuring is a further step in his strategy to navigate the current challenges.8

Prior to these layoffs, Starbucks employed approximately 16,000 individuals in roles outside of its store locations. The job cuts will primarily affect those in corporate support functions.9 However, employees in roasting, manufacturing, warehousing, and distribution will not be affected.

This strategic streamlining reflects Starbucks’ efforts to adapt to a competitive landscape and regain its footing.10 It remains to be seen how these changes will ultimately impact the company’s performance and its ability to re-engage its customer base.

Thinking Fast and Slow, AI Style: Anthropic’s Hybrid Leap

By
Daniel Cruz
-
0

Anthropic is betting on with their latest unveiling

In the relentless race to AI supremacy, it’s not just about being bigger or faster anymore. It’s about being smarter, more nuanced, and, dare we say, more human. And that’s exactly what Anthropic is betting on with their latest unveiling: Claude 3.7 Sonnet, a “hybrid” AI model that promises to revolutionize how we interact with chatbots.1

Forget choosing between lightning-fast responses and carefully considered, in-depth analysis. Anthropic is merging the two, creating a single, unified AI that can handle everything from quick queries to complex problem-solving.2 As co-founder and science chief Jared Kaplan put it, “We want one coherent AI that can help with everything. There’s an advantage in simplicity for our customers.”

This isn’t just another incremental upgrade. It’s a fundamental shift in how AI models are designed. Imagine a brain that can instantly recall a fact while simultaneously pondering a philosophical question. That’s the kind of flexibility Anthropic is aiming for.

The key here is the “hybrid” nature of Claude 3.7 Sonnet. Unlike traditional models that are often specialized for either speed or reasoning, this model seamlessly integrates both capabilities.3 According to Anthropic, they’re the only ones offering this kind of integrated approach right now.

And why does this matter? Well, as product chief Mike Krieger, formerly of Instagram, points out, it simplifies the user experience. “Models all have personalities, they’re all a bit different,” he says. “I would love for people, end users, not have to think about that very much at all.”

No more wrestling with model selection or agonizing over response times. Users can simply engage with Claude 3.7 Sonnet, knowing it will adapt its approach based on the complexity of the task. They can even set a “time budget” to control how much reasoning the AI employs. Plus, Anthropic is rolling out coding agents, adding another powerful tool to their arsenal.4

This move is undoubtedly a direct challenge to AI giants like OpenAI and Google. While Anthropic has already demonstrated a knack for launching innovative features ahead of the competition, this hybrid model could be a game-changer. And it seems even OpenAI CEO Sam Altman is taking note, hinting at a similar direction with a focus on “magic unified intelligence.”

The message is clear: the future of AI isn’t just about raw power; it’s about adaptability and seamless integration. Anthropic’s Claude 3.7 Sonnet is a bold step in that direction, and it will be fascinating to see how the rest of the industry responds.

Nvidia and Other Chip Stocks take a beating and here’s why

By
Daniel Cruz
-
0

Whoa, what a wild ride in the markets! It felt like a rollercoaster this week, with some stocks soaring and others taking a nosedive. Let me break down some of the biggest movers and shakers I’ve been tracking.

First off, the quantum computing sector took a hit. It seems like even Zuckerberg is cooling down on the hype, and that sent stocks like Rigetti Computing and D-Wave Quantum tumbling. Even the Defiance Quantum & AI ETF felt the pressure. It’s a reminder that even exciting emerging technologies can have their ups and downs.

Then there was the chip sector, reacting to the new export restrictions on AI chips. Nvidia, a big player in that space, saw a dip, and it pulled down other chip stocks with it. Micron Technology was particularly affected. It’s interesting to see how geopolitical decisions can ripple through the market like that.

Moderna really got hammered, losing over 20% after they lowered their sales projections for 2025. Cutting guidance by a billion dollars is never good news, and investors clearly weren’t happy.

Crypto stocks also had a rough time, mirroring Bitcoin’s slump below $90,000. Coinbase, Mara Holdings, and MicroStrategy all felt the pain. It just shows how closely these stocks are tied to the crypto market’s volatility.

Pinterest saw a 4% drop after Jefferies downgraded the stock. They cited “underwhelming” growth and lowered their revenue and profit forecasts. It seems like the market is becoming more discerning about growth potential.

Edison International had a really tough week, with shares dropping 13% amidst the wildfires in Los Angeles. The investigation into whether their infrastructure played a role in starting a fire definitely spooked investors.

On the brighter side, e.l.f. Beauty got a boost from Morgan Stanley upgrading the stock. They think the valuation looks more attractive after the pullback we saw in the latter half of 2024. Sometimes, a dip can create a buying opportunity.

Howard Hughes Holdings jumped 9% after Bill Ackman proposed a merger. It’s always interesting to see how merger news impacts stock prices.

Managed care stocks had a good run, thanks to the proposed increase in Medicare Advantage reimbursement rates. Humana, CVS Health, and UnitedHealth all saw nice gains. It looks like investors are betting on the positive impact of this policy change.

U.S. Steel also had a strong week after news broke about a potential joint takeover bid from Cleveland Cliffs and Nucor. It seems like the market loves a good takeover battle.

The megacap tech sector generally saw declines, likely due to rising Treasury yields. Nvidia, Apple, Meta, Microsoft, and Alphabet all experienced losses. It’s a reminder that macro factors can impact even the biggest companies.

Intra-Cellular Therapies absolutely skyrocketed after Johnson & Johnson announced they were acquiring the company. That’s a huge premium for shareholders, and it’s always exciting to see a big acquisition like this.

Finally, Abercrombie & Fitch and Macy’s both disappointed investors with their updated forecasts. Abercrombie & Fitch’s lowered holiday expectations and Macy’s weaker-than-expected sales figures sent their stocks tumbling. It seems like the retail sector is facing some headwinds.

Overall, it was a week of significant movement in the markets, driven by a mix of company-specific news, macroeconomic factors, and sector-specific trends. It definitely keeps things interesting!

Trump Media’s ($DJT) Potential Acquisition of Bakkt Sparks Market Frenzy: A Closer Look at the Strategic Implications

By
Daniel Cruz
-
0

Trump Media is making waves once again, this time with its reported move to acquire the cryptocurrency trading firm Bakkt. According to the Financial Times, the two companies are in “advanced talks” about a potential acquisition. This news sent shares of both Trump Media and Bakkt soaring, capturing the attention of investors and market analysts alike. Let’s explore the details of this development, its potential impact on the financial markets, and the strategic insights behind this move.

Introduction: A High-Stakes Deal That Shook the Market

Trump Media, the majority owner of the Truth Social app and publicly traded on Nasdaq under the ticker DJT, surged by double digits following the acquisition report, closing the day more than 16% higher. Meanwhile, Bakkt, which was created by Intercontinental Exchange (ICE), the parent company of the New York Stock Exchange, saw its shares skyrocket by more than 162%, experiencing multiple trading halts due to extreme volatility.

This potential acquisition comes as President-elect Donald Trump prepares to enter the White House on January 20, 2025. The move signifies Trump Media’s growing footprint in the cryptocurrency and tech sectors, positioning it for a significant strategic shift.

Background on Bakkt: A History of Growth and Challenges

Founded in 2018 and headquartered in Alpharetta, Georgia, Bakkt was established to provide innovative tech services tailored for cryptocurrency investors. Initially hailed as a transformative player in the digital asset space, Bakkt’s journey has been marked by both growth and obstacles.

  • Financial Performance: In its most recent fiscal quarter, Bakkt reported revenue of $328.4 million with an operating loss of $27.4 million. Notably, this represented a 48% improvement compared to the previous year, indicating the company’s efforts to stabilize its financials and improve operational efficiency.
  • Stock Performance: Earlier this year, Bakkt faced a significant challenge when the New York Stock Exchange warned the company that it risked being delisted due to its stock trading below the $1 per share minimum for 30 consecutive trading days. To address this, Bakkt executed a reverse stock split at a 1-for-25 ratio in April to regain compliance and stabilize its market position.

The Trump Media-Bakkt Connection: Strategic Synergies and Opportunities

This reported acquisition aligns with Trump Media’s broader ambitions of diversifying its portfolio and capitalizing on emerging financial technologies. Although Trump Media has experienced volatility in its market value—fluctuating by billions due to political and investor sentiment—its strategic investments signal a long-term commitment to growth.

Key Points of Strategic Interest:

  1. Diversification into Cryptocurrency: The acquisition of Bakkt would position Trump Media as a notable player in the crypto trading and blockchain technology space. This move builds on Trump’s recent promotion of a new cryptocurrency venture, World Liberty Financial (WLF), through which the Trump family is set to receive 75% of net coin revenue.
  2. Expanding the Tech Ecosystem: Bakkt’s infrastructure and services could complement Trump Media’s digital initiatives, including Truth Social, by integrating financial technologies and expanding its user offerings.
  3. Strengthening Market Perception: Despite reporting a net loss of $363 million on just $2.6 million in revenue this year, Trump Media boasts a robust market cap of over $7 billion and holds nearly $673 million in cash and cash equivalents. This cash-rich position enables Trump Media to pursue acquisitions that can enhance its growth trajectory and appeal to investors looking for exposure to tech and crypto assets.

Key Players: Ties That Bind

An intriguing subplot to this deal is the connection between Kelly Loeffler, a former CEO of Bakkt, and Donald Trump’s political circle. Loeffler, who is married to Jeffrey Sprecher, CEO of Intercontinental Exchange, left Bakkt in 2019 to take up a U.S. Senate seat in Georgia, which she lost to Senator Raphael Warnock in a special election. Loeffler’s involvement in Trump’s inauguration committee adds an interesting dynamic to the relationship between Bakkt and Trump Media, potentially facilitating smoother collaboration and strategic alignment.

Market Reaction and Implications

The market’s reaction to the potential acquisition was immediate and dramatic:

  • Trump Media’s Stock: A surge of over 16% in stock value reflects investor optimism about the company’s expansion strategy.
  • Bakkt’s Stock: The over 162% jump, coupled with repeated trading halts due to volatility, underscores the significant interest and potential upside investors see in this deal. This development represents a dramatic shift for Bakkt, which has struggled with stock price stability earlier in the year.

Challenges and Considerations

While this potential acquisition offers significant growth opportunities, several challenges remain:

  • Regulatory Scrutiny: As Trump prepares to take office in January 2025, any major business dealings involving Trump Media could attract heightened regulatory and political scrutiny.
  • Integration Risks: Successfully integrating Bakkt’s operations into Trump Media’s ecosystem will be crucial for realizing the full potential of the acquisition.
  • Market Volatility: The cryptocurrency market is inherently volatile. Any missteps in managing Bakkt’s offerings or regulatory challenges in the crypto space could impact Trump Media’s financial performance and investor confidence.

Strategic Insights: Why This Matters

The acquisition of Bakkt by Trump Media, if completed, would signify a strategic push into the rapidly growing cryptocurrency market, leveraging Bakkt’s established infrastructure and technology. This move could:

  • Bolster Revenue Streams: Integrating crypto trading services could diversify and strengthen Trump Media’s revenue model, moving beyond the limited income currently generated by Truth Social.
  • Enhance Competitive Position: As traditional media and tech companies increasingly explore fintech and blockchain opportunities, Trump Media’s expansion into crypto could position it competitively in both tech and finance sectors.
  • Attract Investor Interest: With cryptocurrency still viewed as a high-growth sector, this move may attract a new wave of investors interested in tech-forward, diversified holdings.

Conclusion: A Bold Step Forward

Trump Media’s potential acquisition of Bakkt is a bold strategic move that reflects its ambition to expand beyond traditional media into the dynamic world of cryptocurrency and blockchain technology. While the deal carries risks associated with integration, regulation, and market volatility, the potential rewards in terms of market positioning and revenue diversification are compelling.

As Trump Media continues to build its business portfolio, investors and market watchers will keep a close eye on how this acquisition unfolds and how it aligns with Trump’s broader business and political strategies. For now, the surge in both companies’ stock prices signals strong market interest and optimism about the path ahead.

Super Micro ($SMCI) Under Scrutiny: A Top Stock Analyst’s Perspective

By
Rachel Kim
-
0

Super Micro Computer’s recent 12% stock plunge, triggered by news of a Justice Department probe and preceding allegations from Hindenburg Research, presents a challenging scenario for investors. While the company has been riding the AI boom, these developments cast a shadow on its financial integrity and future prospects.

The Probe and its Implications

The Justice Department’s probe, particularly its focus on a former employee’s allegations of accounting violations, adds significant weight to Hindenburg’s claims of financial impropriety. While these investigations are in their early stages and require further scrutiny, they raise concerns about the accuracy of Super Micro’s financial reporting and its potential impact on the company’s valuation.

Key Takeaways for Investors

  1. Heightened Uncertainty: The ongoing investigations introduce a high degree of uncertainty, making Super Micro a riskier investment proposition. Until the investigations conclude, investors should exercise caution and brace for potential volatility.
  2. Potential Impact on Valuation: If the allegations are substantiated, it could lead to significant financial restatements, impacting Super Micro’s profitability and valuation. Investors should closely monitor the investigations and factor in the potential downside risk.
  3. Business Outlook: While the AI boom presents significant growth opportunities for Super Micro, the ongoing investigations and potential financial repercussions could disrupt its operations and hinder its ability to capitalize on this trend. Investors should reassess their growth expectations for the company.
  4. Trust and Reputation: The allegations, regardless of their ultimate outcome, could damage Super Micro’s reputation and investor confidence. Rebuilding trust could be a long and arduous process, potentially impacting the company’s ability to attract new customers and partners.

Actionable Insights

  • Existing Shareholders: Exercise caution and consider reducing exposure to Super Micro, particularly if you have a low risk tolerance. Closely monitor the investigations and their potential impact on the company’s financials and operations.
  • Potential Investors: Defer any investment decisions until the investigations conclude and a clearer picture emerges. Focus on alternative companies in the AI space with stronger financial track records and less regulatory overhang.
  • Industry Watchers: The Super Micro situation highlights the importance of due diligence and risk management when investing in high-growth sectors like AI. Scrutinize financial statements, governance practices, and any red flags raised by short-sellers or analysts.

Conclusion

The Justice Department probe and preceding allegations from Hindenburg Research have significantly impacted Super Micro’s outlook. While the company operates in a promising industry, investors must weigh the potential risks associated with the ongoing investigations against its growth prospects. Until a clearer picture emerges, a cautious approach is warranted.

Disclaimer: The information provided in this analysis is for educational and informational purposes only and should not be construed as financial advice. Investing involves risks, and past performance is not indicative of future results. Please consult with a qualified financial advisor before making any investment decisions.  

Decoding the Bear Steepener: A Market Analyst’s Perspective

By
Daniel Cruz
-
0

The recent dynamics in the Treasury market, marked by a surge in long-term yields despite the Federal Reserve’s aggressive rate cut, present a fascinating yet potentially concerning scenario for investors. The emergence of a bear steepener in the yield curve, characterized by a widening gap between 10-year and 2-year Treasury yields, merits close scrutiny as it hints at a complex interplay of market expectations and economic realities.

Market’s Premature Easing Bets

The bond market’s initial reaction, with long-term yields declining sharply in anticipation of the Fed’s move, suggests a degree of over-optimism. It seems market participants had priced in a more aggressive easing cycle than what the Fed ultimately delivered, even with the substantial 50 basis point cut. This misalignment between market expectations and the Fed’s guidance has contributed to the subsequent surge in long-term yields, as the reality of a more gradual easing path sets in.

Inflation Fears and Fiscal Concerns

The bear steepener also reflects growing concerns about inflation. The Fed’s willingness to tolerate higher inflation, coupled with worries about the U.S. fiscal situation and its potential impact on long-term borrowing costs, are contributing to this sentiment. Market participants are increasingly factoring in the possibility that persistent inflation and a mounting debt burden could push long-term interest rates higher, regardless of the Fed’s actions.

Implications for Investors

The current market environment calls for a cautious approach. The bear steepener signals a potential shift in market sentiment, with rising inflation expectations and fiscal concerns taking center stage. Investors should pay close attention to the evolving dynamics in the Treasury market and their implications for different asset classes.

  • Fixed Income: The potential for further increases in long-term yields could negatively impact bond prices, particularly those with longer durations. Investors may consider focusing on shorter-duration bonds or exploring alternative fixed-income strategies to mitigate interest rate risk.
  • Equities: Rising inflation expectations and potential economic headwinds could weigh on equity valuations. Investors may need to adopt a more selective approach, focusing on companies with strong fundamentals and pricing power.
  • Real Assets: Assets like real estate and commodities, which often act as inflation hedges, could become increasingly attractive in the current environment.

Conclusion

The emergence of a bear steepener in the Treasury yield curve underscores the complex interplay between market expectations, Fed policy, and macroeconomic realities. While the market’s initial exuberance following the Fed’s rate cut has subsided, the underlying concerns about inflation and fiscal sustainability remain. Investors should navigate this evolving landscape with caution, adopting strategies that align with their risk tolerance and investment objectives.

Disclaimer: The information provided in this analysis is for educational and informational purposes only and should not be construed as financial advice. Investing involves risks, 1 and past performance is not indicative of future results. Please consult with a qualified financial advisor before making any 2 investment decisions.  

Stocks Rise ahead of Federal Reserve Interest Rate Decision

By
Daniel Cruz
-
0

Stocks jumped Wednesday as major tech names were led higher by NVDA and readied for the Federal Reserve’s latest monetary policy decision

Shares of Pinterest (NYSE: PINS) fell 12% after the company’s forward guidance for the third quarter came in below expectations. Pinterest projected revenue between $885 million and $900 million, lower than the $908.6 million consensus estimate from analysts polled by FactSet. Despite this, the company’s second-quarter earnings and revenue exceeded expectations, as reported by LSEG.

Vistra (NYSE: VST), Match Group (NASDAQ: MTCH), Advanced Micro Devices (NASDAQ: AMD)
Vistra’s stock surged nearly 14% after the Nuclear Regulatory Commission approved its request to continue operating the Comanche Peak Nuclear Power Plant. This license renewal allows Vistra to operate the 2,400-megawatt plant through 2053. Shares of Match Group, the owner of Tinder, rose 13% after reporting second-quarter revenue of $864 million, surpassing the $856.5 million estimate from analysts polled by FactSet. Additionally, Match Group announced plans to exit live streaming services within its dating apps and to discontinue Hyperconnect’s live-streaming app “Hakuna,” which is primarily used in Japan and Korea. AMD’s shares increased by over 4% after the company reported better-than-expected earnings and revenue for the second quarter. The chipmaker posted adjusted earnings of 69 cents per share on revenue of $5.84 billion, beating the analysts’ expectations of 68 cents per share on revenue of $5.72 billion.

Arista Networks (NYSE: ANET), Skyworks Solutions (NASDAQ: SWKS), Upstart (NASDAQ: UPST), DuPont de Nemours (NYSE: DD), Humana (NYSE: HUM), Starbucks (NASDAQ: SBUX), AutoNation (NYSE: AN), Kraft Heinz (NASDAQ: KHC), Marriott International (NASDAQ: MAR), Bunge (NYSE: BG), Constellation Energy (NASDAQ: CEG), Boeing (NYSE: BA)
Arista Networks’ shares jumped 9% after the company reported second-quarter results that exceeded Wall Street’s estimates for both earnings and revenue. The networking company posted adjusted earnings of $2.10 per share on $1.69 billion in revenue. Skyworks Solutions’ stock dropped 6% after reporting fiscal third-quarter adjusted earnings of $1.21 per share, which fell short of analysts’ expectations. However, the company’s revenue of $906 million slightly exceeded the consensus estimate of $900 million, according to LSEG. Upstart’s stock rallied over 10% after Mizuho upgraded the company’s rating from underperform to outperform. Analyst Dan Dolev cited improving risk factors for borrowers and a higher likelihood of lower interest rates as reasons for the upgrade, predicting a 19% rise in Upstart’s shares from Tuesday’s close. DuPont’s shares climbed 5% after the company reported second-quarter earnings that beat Wall Street’s expectations. The chemical maker posted earnings of 97 cents per share, excluding certain items, on revenue of $3.17 billion, surpassing analysts’ estimates of 85 cents per share on revenue of $3.05 billion. DuPont also raised its full-year forecast for earnings and revenue.

Humana’s shares fell 9% after the health insurer issued full-year guidance that fell short of expectations. Humana projected earnings of $16 per share for the year, compared to the $16.34 per share expected by analysts polled by FactSet. Despite reporting weaker-than-expected sales for the fiscal third quarter, Starbucks’ shares rose 4%. The coffee chain reported revenue of $9.11 billion, below the $9.24 billion expected by analysts, but met expectations with adjusted earnings of 93 cents per share. AutoNation’s stock increased 8% despite missing Wall Street’s revenue expectations. The car dealer reported quarterly revenue of $6.48 billion, falling short of the $6.72 billion consensus forecast from analysts polled by LSEG. Shares of Kraft Heinz jumped more than 4% after the company reported better-than-expected second-quarter adjusted earnings. However, the company’s revenue of $6.48 billion came in below the $6.55 billion expected by analysts polled by FactSet. Marriott International’s shares fell over 5% after the company reported second-quarter revenue that missed expectations. The hotel chain posted revenue of $6.44 billion, below the $6.47 billion expected by analysts polled by FactSet. Marriott also issued weaker-than-expected guidance for adjusted earnings in the third quarter, forecasting a range of $2.27 to $2.33 per share, compared to the $2.38 per share expected by analysts.

Bunge’s stock dropped nearly 8% after the company reported second-quarter results that missed analysts’ expectations. Bunge posted adjusted earnings of $1.73 per share on revenue of $13.24 billion, below the $1.83 per share on $14.3 billion in revenue expected by analysts polled by FactSet. Shares of Constellation Energy rose about 11% following results from the mid-Atlantic grid operator PJM’s capacity auction, which cleared a total of 17.5 gigawatts from Constellation between 2025 and 2026. Boeing’s shares jumped 3% after the company announced that Robert “Kelly” Ortberg would replace CEO Dave Calhoun. Ortberg, who previously led aerospace supplier Rockwell Collins, will start his new role on August 8.

123...66Page 1 of 66

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

©